A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...

In 2026, Medicare participants will pay more for their health care. Part B costs are expected to rise more than 10%. Here's ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

You may also be able to strategically position your income to avoid the IRMAA surcharge altogether. Utilizing full or partial ...

Medicare drug plans are increasingly excluding coverage of new specialty drugs that treat complex conditions like cancers and ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The U.S. Government Accountability Office (GAO) says that steps are being taken to address healthcare fraud. For one thing, ...

Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...

Medicare Advantage, the privately run insurance on which roughly 500,000 older Louisiana residents rely for health care, is facing calls for change in Congress.

Working seniors need professional advice when making coverage decisions, but only 21% of retirees with advisers receive ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...